hTEPS are a subset of pharma in the EU: it's official
This article was originally published in Clinica
Executive Summary
The European Commission's proposal for an advanced therapy products Regulation, adopted on November 16, and covering somatic cell and gene therapy as well as human tissue engineered products (hTEPs), has "pharmaceutical" stamped all over it, writes Amanda Maxwell.